BSc (Hons) in Nutrition and Food Science (The University of Reading), MSc in Biomedicine (Lancaster University), MA in NCTJ Journalism (including NCTJ diploma) (Kingston University)
Written For
Bayer (including Berocca, Canesten, Clarityn, Bepanthen and Germoloids), Roche, Holland & Barrett, Nestlé, Cancer Research UK, Alzheimer’s UK.
Known as Patch to most people, Patrick is a Patient Content Lead who enjoys translating complex healthcare topics into clear, patient-focused content.
Before joining Releaf, Patrick developed content marketing strategies for major healthcare and consumer brands, producing everything from feature articles and animations to patient-focused resources and social media campaigns.
His experience across life sciences and pharma has given him a strong understanding of how to balance scientific accuracy and regulatory guidelines with a writing style that’s practical and easy to understand.
At Releaf, Patrick creates evidence-led content designed to make medical cannabis information feel accessible and grounded in clinical research. He is passionate about helping readers feel informed and reassured, while advocating for wider awareness and improved understanding of medical cannabis in the UK.
Acne is estimated to affect approximately 95% of people aged between 11 and 30 years old and is the eighth most common skin disease worldwide. In the UK specifically, it’s one of the most common skin conditions, with the country in the top 10 globally for diagnoses in adolescents and young people. Our skin contains part of the endocannabinoid system, the complex cell-signalling network responsible for keeping our skin healthy by regulating important bodily processes like inflammation and oil (sebum) production.
Living with cancer involves far more than the diagnosis itself, with symptoms like pain, nausea and poor sleep affecting everyday life. For National Cancer Survivors' Day 2026, this guide explores how medical cannabis may support eligible patients in managing cancer-related symptoms as part of a wider, clinician-led care plan.
International Nurses Day 2026 allows us to celebrate the incredible efforts nurses make to ensure patients feel supported throughout their treatment journey. In this article, we explore how Releaf’s medical cannabis nurses offer personalised follow-up care and practical guidance to help patients feel more confident after receiving their prescription.
The relationship between medical cannabis and Parkinson’s disease is a growing area of clinical interest, with more and more papers exploring its potential impact on symptoms like sleep disorders, anxiety, pain and tremors. In support of World Parkinson’s Day, this guide takes a detailed look at what recent clinical research tells us about cannabis-based treatment options for Parkinson’s disease.
Stress can build up slowly and affect how we sleep, feel and cope day to day. For Stress Awareness Month 2026, this guide explores 10 practical ways to manage stress more effectively, while also looking at how medical cannabis may support symptom relief as part of a wider treatment approach.
Real patients share their experiences of taking prescribed medical cannabis for fibromyalgia at Releaf. Stories cover the journey from struggling with conventional treatments to finding relief through specialist-prescribed cannabis, including honest accounts of what worked, what was challenging, and how treatment changed daily life.
The last thing any of us wants when travelling is extra stress. Everyone deserves to feel safe and secure when travelling, regardless of what their medical needs might be. Unfortunately, though, this isn’t always seamless for medical cannabis patients.
Whether you’re planning a summer getaway or a winter break, you may be wondering what’s involved when travelling abroad with your prescribed medical cannabis. Don’t worry, we’ve got you covered.
If you’re planning a trip abroad, it helps to understand how medical cannabis is regulated around the world. This guide gives a broad overview of which countries have medical cannabis laws in place for their own residents.
When researching medical cannabis, you’ll likely encounter the terms ‘indica’ and ‘sativa’ before too long. These simply refer to the two conventional classifications of the Cannabis sativa L. plant.
Chronic back pain is one of the most common reasons that patients start looking into medical cannabis, but can it actually help? And, if so, can you access it within the UK?
The short answer is yes, medical cannabis may help to alleviate the symptoms of chronic back pain. It is also legally available in the UK to eligible patients, who can receive a prescription from a specialist.
Medical cannabis for fibromyalgia comes in several forms, including oils, capsules, and dried flower for vaporisation. Your specialist doctor will prescribe the right type based on your symptoms, with THC-dominant products often used for pain and sleep, and CBD-dominant products for daytime use and anxiety.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."